Pilot Study of Probiotics in Pre-diabetic Adolescents
Completed · Not applicable · Has a placebo group
Conditions studied: Obesity, Childhood
In brief
This study evaluates the feasibility and effect of probiotics on glycemic control in obese adolescents.
Key facts
- Study ID
- NCT03109587
- Run by
- Seattle Children's Hospital
- People needed
- 16
- Starts
- 2018-06-01
- Expected to finish
- 2020-07-31
- Last updated by the study team
- 2020-08-21
Who can join
Age: 13 and older, up to 19. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Male or female, 13-19 y. of age at Visit 1.
- BMI: 99th percentile or greater
- Acanthosis nigricans
- Pubertal Tanner stage ≥3
You may not qualify if…
- Secondary diabetes (i.e. post-transplant diabetes mellitus (DM) or cystic fibrosis DM), monogenic forms of diabetes (i.e. MODY), autoimmune diabetes or presence of islet autoantibodies.
- Known severe immunodeficiency, or immune compromised.
- Current or previous history for insulin or metformin therapy (within last 3 months).
- Antibiotic or probiotic therapy 3 months prior to enrollment.
- Start of new dietary intervention within 1 month prior to enrollment.
- Diagnosed food hypersensitivity or active gastrointestinal disease
Where it is running
- Seattle Children's Hosptital — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.